Romeo A. Majano, M.D., and H. Vernon Anderson, M.D.

Dr. Marjano is Cardiology Fellow and Dr. Anderson is Professor of Medicine, University of Texas Medical.

Dr. Majano reports no commercial conflict of interest. Dr. Anderson reports no commercial conflict of interest.

Release Date: 10/18/2001
Termination Date: 10/18/2004

Estimated time to complete: 1 hour(s).

Albert Einstein College of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Albert Einstein College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Upon completion of this Cyberounds^®, you should be able to:

• Describe the pathophysiology underlying the unstable coronary syndromes
• Discuss the rationale for the combination medical therapies employed for unstable coronary syndromes, the common drug agents used and their actions
• Discuss the basic elements of clinical risk stratification in unstable coronary syndromes, and the arguments for early invasive or early noninvasive approaches.

 

This conference may include discussion of commercial products and services.

The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.

 

Please click below to accept the terms of this CME activity